At what enterprise value was LAGARRIGUE acquired in 2021?

During the acquisition of LAGARRIGUE by NAXICAP PARTNERS in 2021, the transaction's Enterprise Value is estimated to be in the range of 300M - 700M EUR.

What was the EV/EBITDA of LAGARRIGUE when it was acquired by NAXICAP PARTNERS?

The estimated EV/EBITDA multiple for LAGARRIGUE is in the range of 15x - 25x.

When was LAGARRIGUE acquired by NAXICAP PARTNERS?

LAGARRIGUE was acquired by NAXICAP PARTNERS in 2021.

What was the revenue of LAGARRIGUE at the time of the deal?

The revenue of LAGARRIGUE at the time of the deal is estimated to be in the range of 100M - 200M EUR.

What was the EBITDA of LAGARRIGUE during the acquisition?

LAGARRIGUE's EBITDA is estimated to be in the range of 10M - 30M EUR.

How is the data for the LAGARRIGUE acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the LAGARRIGUE deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.ardian.com/fr/communiques-de-presse/ardian-cede-sa-participation-majoritaire-dans-lagarrigue-naxicap-partners

What is the average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026?

The average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026 is 14.5x.

← DATABASE

Home Database Healthcare & PharmaLAGARRIGUE

04/2021

LAGARRIGUE acquired by NAXICAP PARTNERS

FRANCE Life Sciences / Medical Devices / Implants & Prosthetics EV 300M - 700M EUR

Context

Naxicap Partners acquired a majority stake (~80%) in Groupe Lagarrigue from Ardian and iXO Private Equity. The management team reinvested to hold the remaining ~20%. Naxicap prevailed in a competitive auction process managed by Edmond de Rothschild Corporate Finance, beating out offers from IK Investment Partners and Cobepa. The transaction is financed through a unitranche debt facility (likely provided by ArcMont AM) combined with a PIK note (CIC Private Debt), including significant capex lines to fund future external growth.

In the past, the company had already been the subject of several LBOs, notably led by Azulis Capital / Bnp Paribas Developpement / Galia in 2011 and Ardian / Ixo Private Equity in 2016. This succession of buyouts highlights the strong attractiveness of the company's business model.

LAGARRIGUE, which reported an EBITDA margin of in 2021, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (14.5x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Based in Toulouse, Lagarrigue is a leading French provider of external orthopaedic devices (prosthetics and orthotics). The group specializes in custom-made solutions (95% of activity) for patients with disabilities. Under previous ownership, it tripled its size, expanding into Switzerland, Belgium, and Spain, and digitized its operations through software subsidiaries (Rodin 4D, Vorum).

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2021

2020

Other operations with LAGARRIGUE

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
09/2016	ARDIAN / IXO PRIVATE EQUITY	LAGARRIGUE	FRANCE	Implants & Prosthetics
05/2011	AZULIS CAPITAL / BNP PARIBAS DEVELOPPEMENT / GALIA	LAGARRIGUE	FRANCE	Implants & Prosthetics

REFERENCES

Valuation range: EV 300M - 700M EUR

Revenue range: 100M - 200M EUR

EBITDA range: 10M - 30M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of LAGARRIGUE by NAXICAP PARTNERS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: lagarrigue

Acquirer: naxicap partners